Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old

CoronaVac is an inactivated SARS-CoV-2 vaccine that has been rolled out in several low and middle-income countries including Brazil, where it was the mainstay of the first wave of immunization of healthcare workers and the elderly population. We aimed to assess the T cell and antibody responses of v...

Descripción completa

Detalles Bibliográficos
Autores principales: Medeiros, Giuliana X., Sasahara, Greyce Luri, Magawa, Jhosiene Y., Nunes, João Paulo S., Bruno, Fernanda R., Kuramoto, Andreia C., Almeida, Rafael R., Ferreira, Marcelo A., Scagion, Guilherme P., Candido, Érika D., Leal, Fabyano B., Oliveira, Danielle B. L., Durigon, Edison L., Silva, Roberto Carlos V., Rosa, Daniela S., Boscardin, Silvia B., Coelho, Verônica, Kalil, Jorge, Santos, Keity S., Cunha-Neto, Edecio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921991/
https://www.ncbi.nlm.nih.gov/pubmed/35300337
http://dx.doi.org/10.3389/fimmu.2022.812126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921991/
https://www.ncbi.nlm.nih.gov/pubmed/35300337
http://dx.doi.org/10.3389/fimmu.2022.812126

Ejemplares similares